Table 3.

Baseline HRQoL Scores from CASPIAN and IMpower133. D+EP, durvalumab and etoposide platinum; EP, etoposide platinum; A+EP, atezolizumab and etoposide platinum.

	CASPIAN		IMpower133
	D+EP	EP	A+EP	EP
Global Health Status	56.0	54.1	51.6	53.7
Physical Functioning	72.2	70.7	70.7	71.9
Pain	28.4	29.5	33.6	31.9
Appetite Loss	24.2	25.6	28.9	27.4
Cough	41.5	40.5	42.2	42.9
Dyspnoea	36.5	38.5	34.3	29.6
Fatigue	35.3	37.1	42.0	38.7
Insomnia	29.7	33.9	37.6	34.1